期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (4)
Objective: Patient-derived xenograft (PDX) models provide a promising preclinical platform for hepatocellular carcinoma (HCC). However, the molecular ......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (3)
Objective: To examine the association between lymph node status and recurrence patterns in completely resected gastric adenocarcinoma. Methods: We ret......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Gastric cancer, with high morbidity and mortality rates, is one of the most heterogeneous tumors. Radical gastrectomy and postoperative chemotherapy a......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (4)
Objective: Bevacizumab has an important and evolving role in improving outcomes in patients with metastatic colorectal cancer (mCRC) worldwide and was......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (4)
Objective: To validate the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic ductal adenocarcinoma (PDAC) in ......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (4)
Objective: The clinical and biological characteristics of colorectal cancer have been found to differ depending on the anatomic site of the cancer. Ho......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Gastric cancer (GC) is one of the major cancers in China and all over the world. Most GCs are diagnosed at an advanced stage with unfavorable prognosi......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Gastrectomy with lymph node (LN) dissection has been regarded as the standard surgery for gastric cancer (GC), however, the rational extent of lymphad......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Objective: The goal of this study was to get preliminary insight on the intra-tumor heterogeneity in colitis-associated cancer (CAC) and to reveal a p......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Immune checkpoint inhibitors (ICIs), a type of immunotherapy, have become one of the most important therapeutic options for first- and second-line tre......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (3)
Objective: Previous investigations of circulating tumor cells (CTCs) have mainly focused on their genomic or transcriptomic features, leaving their ep......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (3)
Objective: This study aimed to compare the pharmacokinetic, pharmacodynamic and safety profiles of HLX01 (a rituximab biosimilar) and reference rituxi......
期刊： CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (2)
Pancreatic cancer (PC) is one of the deadliest malignancies. The high mortality rate of PC largely results from delayed diagnosis and early metastasis......
